PhRMA-FDA Working Group To Develop Best Practices For Data Mining
Executive Summary
A Pharmaceutical Research & Manufacturers of America-FDA working group is looking at developing "best practices" for data mining techniques to identify potential safety signals
You may also be interested in...
FDA Moves Ahead With Adverse Event Data-Mining; “White Paper” Out Soon
An FDA-PhRMA working group is finalizing a "white paper" on data mining as a tool in postmarketing safety surveillance
FDA Moves Ahead With Adverse Event Data-Mining; “White Paper” Out Soon
An FDA-PhRMA working group is finalizing a "white paper" on data mining as a tool in postmarketing safety surveillance
FDA Adverse Event Data Mining Systems To Be Created By Lincoln Technologies
FDA's agreement with Boston-based Lincoln Technologies to create adverse event data mining technology is the second cooperative research and development agreement between the two